Metraipolis › archive › dc_0e5fef293b57

Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction — Europe PMC PMID:41612231

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41612231
DOI
10.1186/s12885-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-10-18T06:28:37.334Z
SHA-256 of the archived text
9647a65c9f21f5ff618ecce4a6a09905545da548e28b6d1d8e6abfb39fc48a97
Stable URL of this page
https://metraipolis.com/documento/dc_0e5fef293b57

How to cite

Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction — Europe PMC PMID:41612231 — Europe PMC (en), https://europepmc.org/article/MED/41612231 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0e5fef293b57 (Metraipolis archive dc_0e5fef293b57, sha256 9647a65c9f21f5ff618ecce4a6a09905545da548e28b6d1d8e6abfb39fc48a97)
BibTeX
@misc{dc0e5fef293b57,
  title = {Multi-omics characterization of C4orf19 in HNSCC: constructing prognostic signatures for immunotherapy and chemotherapy response prediction — Europe PMC PMID:41612231},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41612231},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0e5fef293b57; sha256 9647a65c9f21f5ff618ecce4a6a09905545da548e28b6d1d8e6abfb39fc48a97},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41612231. Agents can read the archived copy with the MCP tool read_document.